YTS109 cell injection

YTS109 cell therapy · China Immunotech (Beijing) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YTS109 cell injection, covering 2024-08-29 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia [Phase 1]